| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/14/2008 | US20080194626 Antihypertensive drug combination |
| 08/14/2008 | US20080194614 Using mixture of hydroxy-3-methylglutaryl coenzyme a inhibitor and rapamycin; anticholesterol agents; dyslipidemia; atherosclerosis; antiarthritic agents; inflammatory bowel disorders; restenosis; transplant rejection |
| 08/14/2008 | US20080194608 Atherosclerosis therapy; antidiabetic agents; dyslipidemia |
| 08/14/2008 | US20080194598 Pyrimidine Carboxylic Acid Derivatives and Use Thereof |
| 08/14/2008 | US20080194597 Platelet adp receptor inhibitors |
| 08/14/2008 | US20080194584 Nitrogen Heteroaromatic Compounds Which Bind To The Active Site Of Protein Kinase Enzymes |
| 08/14/2008 | US20080194576 Pyrimidine Derivatives and Their Use as P2Y12 Receptor Antagonists |
| 08/14/2008 | US20080194564 the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and processes for the preparation of these |
| 08/14/2008 | US20080194560 a rapidly disintegrating solid dosage form comprising an active pharmaceutical ingredient, a disintegrant and a disintegration promoter, which formulation is obtainable by a wet granulation process |
| 08/14/2008 | US20080194559 Remedy for Angiospasm Accompanying Subarachnoid Hemorrhage Containing Thrombin Receptor Antagonist as the Active Ingredient |
| 08/14/2008 | US20080194549 Organic Compounds |
| 08/14/2008 | US20080194548 combination of a CCR2 antagonist and a statin is useful in the treatment and or prevention of inflammatory and other disorders, and methods of treating inflammatory and other disorders using a combination of a CCR2 antagonist and a statin. |
| 08/14/2008 | US20080194533 Sulfating 17 beta-dihydroequilin or 17 beta-estradiol using tertiary amine-sulfur trioxide complexes and sodium, lithium or potassium salt formation; hormone replacement therapy; hot flashes in postmenopausal women; endometriosis, breast cancer |
| 08/14/2008 | US20080194529 Deuterated 3-(1-Methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin- -5-yl)-N-[2-(1-methyl-pyrrolidin-2-yl)-ethyl]-4-propoxy-benzenesulfonamide; combined with a second active agent; erectile dysfunction; hypotensive agents |
| 08/14/2008 | US20080194524 Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof |
| 08/14/2008 | US20080194513 RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF OCULAR NEOVASCULARIZATION |
| 08/14/2008 | US20080194494 4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia |
| 08/14/2008 | US20080194493 Compositions Containing D-Carnosine |
| 08/14/2008 | US20080194483 GLP-1 (9-36) methods and compositions |
| 08/14/2008 | US20080194481 Albumin Fusion Proteins |
| 08/14/2008 | US20080194475 mutant erythropoietin (EPO) having improved stability as measured by a ratio of the ability of an EPO variant to bind the EPO receptor in the presence of dithiothreitol (DTT), in a radioimmunoassay, versuses the ability in the absence of DTT in the same radioimmunoassay |
| 08/14/2008 | US20080194469 Biodrug such as eptifibatide with blend of a hydrolyzable hydrophobic polymer containing diphenolic tyrosine monomer such as poly(desaminotyrosyltyrosine hexyl ester adipate (Poly(DTH adipate)), and another less hydrophobic hydrolyzable polymer that degrades to form acidic groups, releasing the biodrug |
| 08/14/2008 | US20080194466 (5Z)-5-(6-Quinoxalinylmethylidene)-2-[(2,4,6-Trichlorophenyl)Amino]-1,3-Thiazol-4(5H)-One |
| 08/14/2008 | US20080193949 Using selectin concentration as diagnostic indicator of thrombosis |
| 08/14/2008 | US20080193944 Expression vector comprising nucleotide sequences coding cardiac-related ankyrin-repeat protein kinase (CARK) for diagnosis, treatment and prevention of cardiovascular disorders |
| 08/14/2008 | US20080193573 Using supercritical carbon dioxide extraction method; reduce amyloid plaque aggregate; Alzheimer's disease |
| 08/14/2008 | US20080193530 Use of ranolazine for the treatment of non-coronary microvascular diseases |
| 08/14/2008 | US20080193528 Bosentan; excipients, filler, lubricant, disintegrant, acidifying agent, flavouring, sweetening; endothelin receptor inhibitor; pulmonary arterial hypertension |
| 08/14/2008 | US20080193441 Homogeneous Preparations of Chimeric Protein |
| 08/14/2008 | US20080193423 Small organic molecule regulators of cell proliferation |
| 08/14/2008 | US20080193415 HSA-free formulations of interferon-beta |
| 08/14/2008 | US20080193414 Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases |
| 08/14/2008 | CA2677661A1 Tricyclic compounds |
| 08/14/2008 | CA2677387A1 Nitric oxide donor compounds |
| 08/14/2008 | CA2676498A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | CA2675357A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors |
| 08/13/2008 | EP1956093A1 von Willebrand Factor (vWF)-cleaving protease |
| 08/13/2008 | EP1956082A1 Reversibly inactivated acidified plasmin |
| 08/13/2008 | EP1956079A1 Neural progenitor cells |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1956017A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and method of reducing TNF alpha levels |
| 08/13/2008 | EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 08/13/2008 | EP1956005A1 Delta d Crystaline form of ivabradine hydrochloride, process of preparation thereof and pharmaceutical compositions containing the same |
| 08/13/2008 | EP1955696A2 Use of EDG receptor binding agents in cancer |
| 08/13/2008 | EP1954685A2 Furoxan compounds, compositions and methods of use |
| 08/13/2008 | EP1954677A1 Thiomorpholine compound and process for preparing the same |
| 08/13/2008 | EP1954293A1 Oleuropein for the treatment of conditions associated to the peripheral vascular disease |
| 08/13/2008 | EP1954245A2 Compositions of lipoxygenase inhibitors |
| 08/13/2008 | EP1954128A2 Diphenylmethane derivatives as inhibitors of leukotriene biosynthesis |
| 08/13/2008 | EP1489076B1 Cyclic hemiacetal derivative and use thereof |
| 08/13/2008 | EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
| 08/13/2008 | EP1436279B1 Chemical compounds |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | EP1289916B1 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls |
| 08/13/2008 | EP1200117B1 Lipoprotein lipase (lpl) variant therapeutics |
| 08/13/2008 | EP1137773B1 Growth factor homolog zvegf3 |
| 08/13/2008 | EP0647137B1 Glycine receptor antagonists and the use thereof |
| 08/13/2008 | CN101243103A Therapeutic agent for hypertension |
| 08/13/2008 | CN101243093A New oxabispidine compounds for the treatment of cardiac arrhythmias |
| 08/13/2008 | CN101243077A New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions |
| 08/13/2008 | CN101243076A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 08/13/2008 | CN101243074A Heterocyclic compounds |
| 08/13/2008 | CN101243056A Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 08/13/2008 | CN101243053A N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
| 08/13/2008 | CN101243045A New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases |
| 08/13/2008 | CN101243044A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 08/13/2008 | CN101242830A Nuclear receptors agonists for treatment of atherosclerosis and/or related cardiovascular disease |
| 08/13/2008 | CN101242827A Compositions comprising nebivolol |
| 08/13/2008 | CN101242748A Infant nutrition with protease inhibitor |
| 08/13/2008 | CN101240037A Jelly fungi heptasaccharide and its preparation technique and application |
| 08/13/2008 | CN101240014A Lipopeptid composition with physiological activity and its preparation method and application |
| 08/13/2008 | CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 08/13/2008 | CN101239216A Novel sacculus dilating catheter |
| 08/13/2008 | CN101239151A Chinese medicine and method for preventing and controlling cardiovascular and cerebrovascular diseases |
| 08/13/2008 | CN101239137A Natural medicinal formulations for treating senile dementia and cerebral infarction and preparation thereof |
| 08/13/2008 | CN101239099A Application of Chinese medicinal composition in preparing medicament for treating chronic cardiac insufficiency |
| 08/13/2008 | CN101239095A Method for preparing embolism-extinguishing enteric-coated capsule |
| 08/13/2008 | CN101239092A Kudzuvine flower isoflavonoid extraction, its extracting method, medicinal composition and its use in pharmaceutical |
| 08/13/2008 | CN101239087A Active component for treating cardio-cerebrovascular disease and oral preparation thereof |
| 08/13/2008 | CN101239086A Active component for treating cardio-cerebrovascular disease and injection drug administration preparations thereof |
| 08/13/2008 | CN101239071A Application of HNO in treating heart failure |
| 08/13/2008 | CN101239069A Application of compound capable of supplying active methyl or engaging in methyl migration |
| 08/13/2008 | CN101239067A Medicinal composition |
| 08/13/2008 | CN101239062A Use of 5-HT5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 08/13/2008 | CN101239059A Use of levetiracetam in preparing intelligence-benefiting medicaments |
| 08/13/2008 | CN101239050A Pentoxifylline sustained release tablets and preparation thereof |
| 08/13/2008 | CN101239036A Novel pharmaceutical composition containing the ACE inhibitor ramipril and a dihydropyridine compound |
| 08/13/2008 | CN101239018A Multilayer copolymerized compound membrane soft bagged inosine in sodium chloride injection composition and its manufacturing method |
| 08/13/2008 | CN100410265C Gastrodine derivative, its preparation method, pharmaceutical composition and uses |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/13/2008 | CN100409890C Pharmaceutical composition for treating and preventing thrombus and its preparation method |
| 08/13/2008 | CN100409888C Chinese medicine preparation for curing angiocardiopathy |
| 08/13/2008 | CN100409873C Chinese herbal medicine for treating haemorrhoids and beri-beri |
| 08/13/2008 | CN100409868C Chinese medicine for cardiac and encephalic ischemia |
| 08/13/2008 | CN100409863C Use of shuanghuanglian for preparing medicine for treating arteriolar atherosis |
| 08/13/2008 | CN100409851C Soy daidzin composition and preparation process and use thereof |
| 08/13/2008 | CN100409839C Ginseng-monkshood skeleton slow-release preparation wax skeleton tablet for treating qi athenia and yang depletion and preparing method thereof |